Status and phase
Conditions
Treatments
About
This Study will evaluate the effects of renal function on pharmacokinetics and safety of DA-8010
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
[Healthy Volunteer]
[Renal Impairment Patient]
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
33 participants in 4 patient groups
Loading...
Central trial contact
Anhye Kim, Ph.D
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal